Transactions

Relay Therapeutics, Inc.’s global licensing agreement with Elevar Therapeutics, Inc. for RLY-4008

Date Announced:
12/03/2024

client:
Relay Therapeutics, Inc.

Status:
Closed – 12/03/2024

Value:
Up to $500 million